New York, NY, United States of America

Michael S Weiss

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • New York, NY (US) (2017 - 2021)
  • Boca Raton, FL (US) (2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Michael S. Weiss: A Pioneer in Antibody Therapeutics

Introduction

Michael S. Weiss, based in New York, NY, is a notable inventor with a strong focus on antibody therapeutic innovations. He holds a total of four patents that encompass significant advancements in the treatment of B-cell proliferative disorders. His work primarily involves the development of anti-CD20 antibody compositions and their associated methodologies.

Latest Patents

Michael's latest patents include groundbreaking research on anti-CD20 antibody compositions. This patent describes populations of anti-CD20 antibody proteins with specified ranges of post-translational modifications and outlines methods for utilizing and creating these antibody populations. Furthermore, he has developed innovative methods for combining an anti-CD20 antibody with a PI3K-delta selective inhibitor and a Bruton's tyrosine kinase (BTK) inhibitor. This combination targets B-cell proliferation and provides effective treatments for B-cell hematological malignancies, showcasing his commitment to addressing complex health issues.

Career Highlights

Throughout his career, Michael has made significant contributions to the biotechnology field. He has worked with prominent companies such as TG Therapeutics, Inc. and Laboratoire Francais Du Fractionnement Et Des Biotechnologies. His expertise in antibody therapeutics has positioned him as a key figure in developing life-saving treatments for various diseases.

Collaborations

Michael has had the opportunity to collaborate with esteemed colleagues, including Peter Sportelli and Hari P. Miskin. These collaborations underscore the importance of teamwork in advancing scientific research and innovation, allowing for the integration of diverse perspectives and expertise in the pursuit of groundbreaking medical therapies.

Conclusion

Michael S. Weiss stands out as a remarkable inventor with invaluable contributions to the field of antibody therapies. His innovative patents and collaborative endeavors reflect a dedication to improving the treatment landscape for patients suffering from B-cell proliferative disorders. His continued work promises to yield further advancements in medical science and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…